Back
Lonza Group Vs. NLS Pharmaceutics Industry Stock Comparison
Buy
53
LZAGF
Lonza Group
Last Price:
557.72
Seasonality Move:
10.7%
Sell
27
NLSP
NLS Pharmaceutics
Last Price:
0.13
Seasonality Move:
-28.35%
Buy
53
Lonza Group (LZAGF)
is a Buy
Is Lonza Group a Buy, Sell or Hold?
- The current Lonza Group [LZAGF] share price is $558.78. The Score for LZAGF is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- LZAGF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $0.13. The Score for NLSP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LZAGF Stock Price Chart
What is Lonza Group's stock price today?
-
The Lonza Group share price today is $558.78
The current trend is moderately bearish and LZAGF is experiencing selling pressure, which indicates risk of future bearish movement.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $0.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight buying pressure.
LZAGF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 46 | Sell |
| Chaikin Money Flow: | -23 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (564.57 - 603.43) | Sell |
| Bollinger Bands (100): | (414.76 - 566.06) | Buy |
NLSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 24.78 | Sell |
| Chaikin Money Flow: | 156316 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.13 - 0.19) | Sell |
| Bollinger Bands (100): | (0.24 - 0.52) | Sell |
LZAGF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 565.97 | Sell |
| 20-day SMA: | 585.2 | Sell |
| 50-day SMA: | 554.96 | Buy |
| 200-day SMA: | 489.67 | Buy |
| 8-day EMA: | 564.08 | Sell |
| 20-day EMA: | 571.8 | Sell |
| 50-day EMA: | 550.44 | Buy |
| 200-day EMA: | 511.51 | Buy |
NLSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.14 | Sell |
| 20-day SMA: | 0.15 | Sell |
| 50-day SMA: | 0.27 | Sell |
| 200-day SMA: | 0.58 | Sell |
| 8-day EMA: | 0.14 | Sell |
| 20-day EMA: | 0.16 | Sell |
| 50-day EMA: | 0.25 | Sell |
| 200-day EMA: | 0.54 | Sell |
Lonza Group Earnings Growth & LZAGF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lonza Group Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NLS Pharmaceutics Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||